Evidence map›Paper›PMID 38168408›Full record

ArticleResearch square2023

Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease.

Javier Arranz, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, Rosa Ferrer, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 16 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Javier ArranzIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Nuole ZhuIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Sara Rubio-GuerraIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Íñigo Rodríguez-BazIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Rosa FerrerIR SANT PAU, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona.
María Carmona-IraguiIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Isabel BarroetaIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Ignacio Illán-GalaIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Miguel Santos-SantosIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Juan ForteaIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Alberto LleóIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Mireia TondoIR SANT PAU, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona.
Daniel AlcoleaIR SANT PAU, Hospital de la Santa Creu i Sant Pau.
Hospital de Sant Pau · ESUniversitat Autònoma de Barcelona · ES

Funding

The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Bilingual Factors Associated with Cognitive Reserve and Linguistic Resilience in Hispanics with Primary Progressive AphasiaR01AG080470 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI Stephanie M Grasso · 2023 to 2026
$2.8M
Biological Correlates of Alzheimer in Down Syndrome.R21AG056974 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 2017 to 2018
$414k
NIA NIH HHS R01 AG080470NIA NIH HHS R21 AG056974NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566
6 · The paper itself

Abstract

backgroundRecently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown.

methodsWe analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ

resultsPlasma pTau

conclusionThe evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau

Indexed as

AlzheimerAmyloidBiomarkersBloodPlasmaTau

Identifiers

PMID38168408
PMCPMC10760237
OpenAlexW4389664568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.